Disease modification in migraine: A concept that has come of age?

被引：24

作者：

Loder, E ^{[1
]}

Biondi, D ^{[1
]}

机构：

[1] Spaulding Rehabil Hosp, Boston, MA 02114 USA

来源：

HEADACHE | 2003年 / 43卷 / 02期

关键词：

migraine; disease progression; disease modification; disability prevention;

D O I：

10.1046/j.1526-4610.2003.03033.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：135 / 143

页数：9

共 51 条

[1]

[Anonymous], 1999, Drug treatments for the prevention of migraine headache

[2]

Balottin U, 1997, DEV MED CHILD NEUROL, V39, P26

[3] Central sensitization in tension-type headache - possible pathophysiological mechanisms [J].

Bendtsen, L .

CEPHALALGIA, 2000, 20 (05) :486-508

[4]

BURSTEIN R, 2002, 44 ANN SCI M AM HEAD

[5] Drug treatment effects on disease progression [J].

Chan, PLS ;

Holford, NHG .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :625-659

[6] MIGHT MIGRAINE DAMAGE THE BRAIN [J].

CHRONICLE, E ;

MULLENERS, W .

CEPHALALGIA, 1994, 14 (06) :415-418

[7] Possible predictive factors in the prognosis of migraine with aura [J].

Cologno, D ;

Torelli, P ;

Manzoni, GC .

CEPHALALGIA, 1999, 19 (09) :824-830

[8] ANALGESIC-INDUCED CHRONIC HEADACHE - LONG-TERM RESULTS OF WITHDRAWAL THERAPY [J].

DIENER, HC ;

DICHGANS, J ;

SCHOLZ, E ;

GEISELHART, S ;

GERBER, WD ;

BILLE, A .

JOURNAL OF NEUROLOGY, 1989, 236 (01) :9-14

[9] Disease modification in rheumatoid arthritis with leflunomide [J].

Emery, P .

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1999, 28 :9-14

[10] Sumatriptan nasal spray and cognitive function during migraine: Results of an open-label study [J].

Farmer, K ;

Cady, R ;

Bleiberg, J ;

Reeves, D ;

Putnam, G ;

O'Quinn, S ;

Batenhorst, A .

HEADACHE, 2001, 41 (04) :377-384

← 1 2 3 4 5 6 →